We are live on ! Find out more
FA

FDx Advisors Portfolio holdings

AUM $313M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+18.92%
3 Year Est. Return
+56.32%
5 Year Est. Return
+58.97%
10 Year Est. Return
+208.95%
AUM
$1.2B
AUM Growth
+$195M
Cap. Flow
+$161M
Cap. Flow %
13.41%
Top 10 Hldgs %
25.58%
Holding
818
New
169
Increased
465
Reduced
116
Closed
56

Sector Composition

Rank Sector Weight
1 Financials 8.08%
2 Technology 7.31%
3 Healthcare 7.08%
4 Consumer Discretionary 5.63%
5 Industrials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
51
Canadian National Railway
CNI
$78.3B
$3.77M 0.31%
67,034
+7,222
+12% +$398K
LVS icon
52
Las Vegas Sands
LVS
$30.5B
$3.77M 0.31%
46,630
-2,756
-6% -$222K
COP icon
53
ConocoPhillips
COP
$147B
$3.69M 0.31%
52,492
+3,866
+8% +$259K
GILD icon
54
Gilead Sciences
GILD
$161B
$3.65M 0.3%
51,548
+16,456
+47% +$1.29M
JNJ icon
55
Johnson & Johnson
JNJ
$635B
$3.58M 0.3%
36,419
+13,469
+59% +$1.25M
PM icon
56
Philip Morris
PM
$301B
$3.55M 0.3%
43,398
+7,531
+21% +$608K
CSCO icon
57
Cisco
CSCO
$450B
$3.55M 0.3%
158,280
+35,554
+29% +$786K
NEU icon
58
NewMarket
NEU
$7.17B
$3.42M 0.29%
8,761
+838
+11% +$297K
BLK icon
59
Blackrock
BLK
$164B
$3.33M 0.28%
10,587
+204
+2% +$62.4K
SBUX icon
60
Starbucks
SBUX
$118B
$3.3M 0.28%
90,064
+35,466
+65% +$1.31M
AGN
61
DELISTED
Allergan plc
AGN
$3.27M 0.27%
15,865
+11,707
+282% +$2.32M
HSBC icon
62
HSBC
HSBC
$355B
$3.23M 0.27%
73,857
+8,488
+13% +$385K
BMY icon
63
Bristol-Myers Squibb
BMY
$127B
$3.19M 0.27%
61,329
-1,754
-3% -$93.3K
MO icon
64
Altria Group
MO
$122B
$3.17M 0.27%
84,826
+10,743
+15% +$390K
LOW icon
65
Lowe's Companies
LOW
$116B
$3.17M 0.26%
64,767
+7,769
+14% +$375K
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.11M 0.26%
24,906
+10,049
+68% +$1.17M
GLW icon
67
Corning
GLW
$126B
$3.08M 0.26%
147,773
+17,667
+14% +$332K
SAP icon
68
SAP
SAP
$187B
$3.06M 0.26%
37,680
+12,630
+50% +$1M
FMS icon
69
Fresenius Medical Care
FMS
$13.2B
$3.04M 0.25%
87,268
+3,380
+4% +$118K
BUD icon
70
AB InBev
BUD
$158B
$3.02M 0.25%
28,704
+5,261
+22% +$534K
GD icon
71
General Dynamics
GD
$105B
$3.01M 0.25%
27,621
-2,565
-8% -$266K
INTC icon
72
Intel
INTC
$466B
$2.96M 0.25%
114,696
-10,755
-9% -$268K
MSFT icon
73
Microsoft
MSFT
$2.84T
$2.93M 0.24%
71,564
+10,445
+17% +$392K
VTWO icon
74
Vanguard Russell 2000 ETF
VTWO
$17.3B
$2.93M 0.24%
62,964
+3,550
+6% +$163K
JPM icon
75
JPMorgan Chase
JPM
$939B
$2.91M 0.24%
47,983
+17,709
+58% +$1.02M

Similar funds

FDx Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, FDx Advisors held 818 positions worth $1.2B, up 19% from $1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

FDx Advisors deployed $161M of net new capital in Q1 2014, opening 169 new positions and adding to 465 existing holdings. Its largest new stake was Eli Lilly: 43,355 shares worth $2.55M.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.5% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $22.7M trimmed.

  • FDx Advisors's largest Q1 2014 buy was Eli Lilly: 43,355 shares worth $2.55M.
  • FDx Advisors added most to iShares S&P 500 Growth ETF in Q1 2014, an estimated $18.3M increase.
  • FDx Advisors's biggest Q1 2014 reduction was Novo Nordisk, cutting an estimated $22.7M.
  • FDx Advisors fully exited WisdomTree Japan Hedged Equity Fund in Q1 2014, selling an estimated $14M.
  • FDx Advisors's ten largest holdings make up 26% of its $1.2B portfolio in Q1 2014.
  • FDx Advisors opened 169 new positions and closed 56 in Q1 2014.
  • FDx Advisors's portfolio value rose 19% quarter-over-quarter to $1.2B.

Based on FDx Advisors's 13F filing for Q1 2014, filed 15 May 2014.